Atlas Trials

Safety, Attenuation and Immunogenicity of GAP3KO Administered Via A Stephensi Mosquitoes

Clinical trial NCT02313376 · COMPLETED

Trial details

NCT number
NCT02313376
Sponsor
Seattle Children's Hospital
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Malaria
Start date
2014-12-01
Primary completion
2015-02-01
Enrollment
10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.